CEO SUMMARY: It often takes two to four years before payer coverage and reimbursement become stable. During that time, NorDx Laboratories wants the vendors who sell it new molecular assays to have some “skin in the game.” It accomplishes this by negotiating contracts that link the contract’s renewal to NorDx’s success in getting both payers […]
To access this post, you must purchase The Dark Report.